| A Study of LY3039478 in Participants With Advanced Cancer (NCT01695005) | Eli Lilly and Company | 2012-10-01 |
| A Pilot Study of Genetically Engineered NY-ESO-1 Specific NY-ESO-1ᶜ²⁵⁹T in HLA-A2+ Patients With Synovial Sarcoma (NCT01343043) | GlaxoSmithKline | 2012-09-27 |
| A Study of ZSTK474 in Japanese Patients With Advanced Solid Malignancies (NCT01682473) | Zenyaku Kogyo Co., Ltd. | 2012-09-20 |
| Phase I/II Study of APS001F With Flucytosine and Maltose in Solid Tumors (NCT01562626) | Anaeropharma Science, Inc. | 2012-09-01 |
| Trial on Innovative Technologies in Colonoscopy (NCT01688557) | Jagiellonian University | 2012-09-01 |
| Botulinum Toxin A (Botox) in Tissue Expander Breast Reconstruction (NCT01591746) | Mayo Clinic | 2012-08-01 |
| A Study of Aneustat (OMN54) in Patients With Advanced Cancer and Lymphomas (NCT01555242) | Omnitura Therapeutics, Inc. | 2012-08-01 |
| Determination of Drugs and Their Metabolites in Hospitalized Patients (NCT01702545) | Klinikum Nürnberg | 2012-08-01 |
| An Extension Study to Provide Continued Bevacizumab Therapy to Participants With Solid Tumors Who Were Previously Enrolled in a Roche/Genentech Sponsored Study (NCT01588184) | Hoffmann-La Roche | 2012-07-13 |
| A Study of IMC-TR1 in Participants With Advanced Solid Tumors (NCT01646203) | Eli Lilly and Company | 2012-07-01 |
| The EPIC Trial The Elderly Patient Individualized Chemotherapy Trial (NCT03402048) | University of Turin, Italy | 2012-07-01 |
| Efficacy of Tranexamic Acid in Brain Tumor Resections (NCT01655927) | Colombian Foundation for Epilepsy and Neurological Disease | 2012-07-01 |
| Safety, Pharmacokinetics, Pharmacodynamics and Anti-tumor Activity of Sorafenib and Eribulin in Combination (NCT01585870) | Bayer | 2012-07-01 |
| A Phase II Study to Evaluate Efficacy and Safety of Dovitinib (TKI258) in Advanced Scirrhous Gastric Carcinoma Patients (NCT01576380) | Novartis Pharmaceuticals | 2012-06-01 |
| Investigate the Safety and Tolerability of AZD6244 Monotherapy or + Docetaxel in Japanese Patients With Advanced Solid Malignancies or Non-Small Cell Lung Cancer (NCT01605916) | AstraZeneca | 2012-06-01 |
| Smart-phone Application to Promote Medication Adherence in Adolescents and Young Adults (AYA) With Cancer (NCT01618344) | University of Utah | 2012-05-01 |
| A Phase I Study of OSI-906 in Combination With Pemetrexed in Advanced Solid Tumor Malignancies (NCT01567384) | Emory University | 2012-05-01 |
| A Pilot Study To Assess Guidance in and Subsequent Use of Mind-Body Techniques on the Quality of Life of Cancer Patients (NCT01586546) | Absenger Cancer Education Foundation | 2012-05-01 |
| Pilot and Feasibility Study of the Imaging Potential of EC17: Intraoperative Folate-fluorescein Conjugate (EC17) Lung Cancer (CA) (NCT01778920) | University of Pennsylvania | 2012-04-01 |
| A Study Evaluating the Safety, Tolerability, and Pharmacokinetics of GDC-0973 in Combination With GDC-0068 When Administered in Participants With Locally Advanced or Metastatic Solid Tumors (NCT01562275) | Genentech, Inc. | 2012-04-01 |
| FdCyd and THU for Advanced Solid Tumors (NCT01534598) | National Cancer Institute (NCI) | 2012-03-05 |
| Study of DC Vaccination Against Glioblastoma (NCT01567202) | Huashan Hospital | 2012-03-01 |
| Detecting the Impact of Statin Therapy On Lowering Risk of Venous Thrombo-Embolic Events (DISOLVE) (NCT01524653) | University of Vermont | 2012-03-01 |
| RSSearch Patient Registry-Long Term Study of Use of SRS/SBRT (NCT01885299) | The Radiosurgery Society | 2012-03-01 |
| Clinical and Genetic Studies of Li-Fraumeni Syndrome (NCT01443468) | National Cancer Institute (NCI) | 2012-01-17 |
| Cancer Vaccine Targeting Brachyury Protein in Tumors (NCT01519817) | National Cancer Institute (NCI) | 2012-01-05 |
| Study of VGX-100 Administered Alone and Co-administered With Bevacizumab in Adult Subjects With Advanced Solid Tumors (NCT01514123) | Circadian Technologies Ltd. | 2011-12-29 |
| A Study of RO5479599 Alone or in Combination With Cetuximab or Erlotinib in Participants With Metastatic and/or Locally Advanced Malignant Human Epidermal Growth Factor Receptor (HER3) Expressing Solid Tumors of Epithelial Cell Origin (NCT01482377) | Hoffmann-La Roche | 2011-12-01 |
| Phase 1 Study of PI3 (Phosphatidylinositol-3)-Kinase Inhibitor Copanlisib With Gemcitabine or Cisplatin Plus Gemcitabine in Patients With Advanced Cancer (NCT01460537) | Bayer | 2011-11-18 |
| A First-In-Human Study of RO5503781 in Participants With Advanced Malignancies Except Leukemia (NCT01462175) | Hoffmann-La Roche | 2011-11-01 |
| ZoNantax - Zolendronic Acid as Neoadjuvant Therapy Plus Anthracycline and Taxane in Locally Advanced Breast Cancer (NCT01472146) | Susanne Crocamo | 2011-10-01 |
| The Use of Botulinum Toxin A in Two-Stage Tissue Expander/ Implant Breast Reconstruction (NCT01427400) | University of British Columbia | 2011-10-01 |
| Improving Complete Endoscopic Mucosal Resection (EMR) of Colorectal Neoplasia (NCT01471756) | Mayo Clinic | 2011-10-01 |
| The Usefulness of Endoscopic Ultrasound-guided Biliary Drainage With a Newly Designed Hybrid Metallic Stent (NCT01862198) | Inje University | 2011-09-01 |
| Response to Influenza Vaccine in Patients With Non-Hematologic Malignancies Receiving Chemotherapy (NCT01695733) | Washington University School of Medicine | 2011-09-01 |
| Phase I Study of PI3(Phosphoinositol 3)-Kinase Inhibitor BAY80-6946 With Paclitaxel in Patients With Advanced Cancer (NCT01411410) | Bayer | 2011-08-24 |
| Japanese BAY80-6946 Monotherapy Phase I Study (NCT01404390) | Bayer | 2011-08-18 |
| BAY73-4506 Probe Substrate Study (NCT01287598) | Bayer | 2011-08-02 |
| Phase I and Pharmacokinetic Study of Mitoxantrone Hydrochloride Liposome Injection (NCT02043756) | CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | 2011-08-01 |
| Anti Xa Activity in Cancer Patients Receiving Low-molecular-weight Heparin for Venous Thromboembolism (NCT02898051) | Assistance Publique - Hôpitaux de Paris | 2011-08-01 |
| ABT-888, Carboplatin, and Paclitaxel for Cancer With Liver or Kidney Problems (NCT01419548) | National Cancer Institute (NCI) | 2011-07-29 |
| Clinical Evaluation of a New Form of Cancer Therapy (Atavistic Chemotherapy) Based on the Principles of Atavistic Metamorphosis (2011) (NCT02366884) | Dr. Frank Arguello Cancer Clinic | 2011-07-26 |
| Phase I Trial of BI 836845 for Various Solid Cancer (NCT01403974) | Boehringer Ingelheim | 2011-07-19 |
| A Study of the Safety and Pharmacokinetics of AGS-22M6E in Subjects With Malignant Solid Tumors That Express Nectin-4 (NCT01409135) | Astellas Pharma Inc | 2011-07-11 |
| Safety and Clinical Pharmacology of GDC-0068 in Combination With Docetaxel, Fluoropyrimidine Plus Oxaliplatin, Paclitaxel, or Enzalutamide in Participants With Advanced Solid Tumors (NCT01362374) | Genentech, Inc. | 2011-07-11 |
| Phase Ib Study of PI3(Phosphoinositol 3)-Kinase Inhibitor Copanlisib With MEK (Mitogen-activated Protein Kinase) Inhibitor Refametinib (BAY86-9766) in Patients With Advanced Cancer (NCT01392521) | Bayer | 2011-07-01 |
| A Study of RO5458640 in Patients With Advanced Solid Tumors (NCT01383733) | Hoffmann-La Roche | 2011-07-01 |
| A Study of BI 853520 in Patients With Various Types of Advanced or Metastatic Cancer (NCT01335269) | Boehringer Ingelheim | 2011-07-01 |
| Efficacy and Safety of Palonosetron Hydrochloride in the Prevention of Nausea and Vomiting (NCT01481831) | Shanghai Changzheng Hospital | 2011-07-01 |
| Asian Phase I Study Of PF-03446962 (NCT01337050) | Pfizer | 2011-07-01 |
| A Study of IMC-CS4 in Subjects With Advanced Solid Tumors (NCT01346358) | Eli Lilly and Company | 2011-06-15 |
| A Study of RO5429083 in Patients With Metastatic and/or Locally Advanced, CD44-Expressing, Malignant Solid Tumors (NCT01358903) | Hoffmann-La Roche | 2011-06-01 |
| A Study in Metastatic Cancer and Advanced or Metastatic Unresectable Pancreatic Cancer (NCT01373164) | Eli Lilly and Company | 2011-06-01 |
| A Study of Vemurafenib (RO5185426) in Participants With Metastatic or Unresectable Papillary Thyroid Cancer Positive for the BRAF V600 Mutation (NCT01286753) | Hoffmann-La Roche | 2011-06-01 |
| National Evaluation of the Adherence to Recommendations of Venous Thrombo Embolism Treatment in Cancer Patients (NCT01362933) | Floralis | 2011-05-01 |
| Yoga Cancer Rehabilitation Study: A Randomized Trial of Adaptive Yoga for Older Cancer Survivors (NCT01324102) | VA Office of Research and Development | 2011-05-01 |
| BI 6727 (Volasertib) Monotherapy Phase I Trial in Japanese Patients With Advanced Solid Tumours (NCT01348347) | Boehringer Ingelheim | 2011-04-25 |
| Monotherapy Dose Finding With BI 847325 in Solid Tumours (NCT01324830) | Boehringer Ingelheim | 2011-04-15 |
| Trial to Determine MTD of BI 836845 Administered Intravenously Once Every Three Weeks in Patients With Advanced Solid Tumours and Later a Weekly Dosing Schedule in Selected Tumour Types (NCT01317420) | Boehringer Ingelheim | 2011-04-13 |
| Open Label Regorafenib Study to Evaluate Cardiovascular Safety Parameters, Tolerability, and Anti-tumor Activity (NCT01339104) | Bayer | 2011-04-01 |
| Clinical Study to Evaluate the Maximum Tolerated Dose of BAY87-2243 in Patients With Advanced Malignancies (NCT01297530) | Bayer | 2011-04-01 |
| Educational Intervention Targeting Nurses Attitudes and Knowledge About Cancer-related Pain Management (NCT01313234) | Blekinge Institute of Technology | 2011-04-01 |
| A Study of Anti-VEGFR-3 Monoclonal Antibody IMC-3C5 in Subjects With Advanced Solid Tumors (NCT01288989) | Eli Lilly and Company | 2011-03-01 |
| Effect of Rifampin on the Pharmacokinetics of BAY73-4506 (NCT01322438) | Bayer | 2011-03-01 |
| PET-CT in Diagnosis of Pancreatic Cystic Neoplasms (NCT01317836) | Turku University Hospital | 2011-03-01 |
| Mindfulness-based Stress Reduction in Cancer Treatment (NCT01303822) | Universität Duisburg-Essen | 2011-03-01 |
| ALI (Acute Lung Injury) /ARDS (Acute Respiratory Distress Syndrome) in Oncologic Pediatric Patients (NCT01304654) | Grupo de Apoio ao Adolescente e a Crianca com Cancer | 2011-01-08 |
| Pilot Study to Evaluate Individualized Choice of Antidepressants in Patients With Cancer (NCT01725048) | UNC Lineberger Comprehensive Cancer Center | 2011-01-01 |
| Study of Anti-HB-EGF Antibody KHK2866 in Subjects With Advanced Solid Tumors and Ovarian Cancer (NCT01279291) | Kyowa Kirin Co., Ltd. | 2011-01-01 |
| Prospective Phase II Study of Intraoperative Radiotherapy (IORT) in Elderly Patients with Small Breast Cancer (NCT01299987) | Universitätsmedizin Mannheim | 2011-01-01 |
| Bendamustine Hydrochloride Injection for Previously Untreated Chronic Lymphocytic Leukemia (NCT01657955) | Shandong Lanjin Pharmaceuticals Co.,Ltd | 2011-01-01 |
| A Safety Study of Oral ZSTK474 in Patients With Cancer (NCT01280487) | Zenyaku Kogyo Co., Ltd. | 2011-01-01 |
| NP2 Enkephalin For Treatment of Intractable Cancer Pain (NCT01291901) | Diamyd Inc | 2011-01-01 |
| Imaging and Biomarkers of Hypoxia in Solid Tumors (NCT01123005) | Stanford University | 2010-12-01 |
| Exploration of Tumor Accumulation of BAY94-9392 in Patients With Cancer (NCT01186601) | Lantheus Biosciences Ltd. | 2010-12-01 |
| Japanese BAY86-9766 Monotherapy Phase I Study (NCT01179295) | Bayer | 2010-11-19 |
| EZN-2208 (Pegylated SN-38) in Combination With Bevacizumab in Refractory Solid Tumors (NCT01251926) | National Cancer Institute (NCI) | 2010-11-15 |
| A Phase I Study of MK-4827 for Treatment of Solid Tumors (MK-4827-005) (NCT01226901) | Merck Sharp & Dohme LLC | 2010-11-01 |
| An Early Phase I Study of IPdR Absorption, Metabolism, and Safety in Patients With Advanced Solid Tumors and Lymphomas (NCT01240577) | National Cancer Institute (NCI) | 2010-10-26 |
| An Open Label Phase I Dose Escalation Trial of Intravenous BI 6727 (Volasertib)in Combination With Oral BIBW 2992 (Afatinib) in Patients With Advanced Solid Tumours (NCT01206816) | Boehringer Ingelheim | 2010-10-04 |
| Comparing Efficacy of Sorafenib Versus Sorafenib in Combination With Low-dose FP in Patients With Advanced HCC (NCT01214343) | Ministry of Health, Labour and Welfare, Japan | 2010-10-01 |
| Agreement Among Expert Radiologists in Diagnosing Primary Liver Tumors by Magnetic Resonance Imaging (MRI) (NCT01234701) | University of Zurich | 2010-10-01 |
| BIBW 2992 (Afatinib) and Vinorelbine in Japanese Patients With Advanced Solid Tumours (NCT01214616) | Boehringer Ingelheim | 2010-10-01 |
| Using Positron Emission Tomography to Predict Intracranial Tumor Growth in Neurofibromatosis Type II Patients (NCT01222728) | National Institute of Neurological Disorders and Stroke (NINDS) | 2010-09-22 |
| Intended Use Study of the BD SurePath Plus™ Pap (NCT01234480) | Becton, Dickinson and Company | 2010-09-01 |
| A Safety and Efficacy Study of Oral Tapentadol Extended-Release in Japanese Participants (NCT01309386) | Janssen Pharmaceutical K.K. | 2010-08-01 |
| A Study of RO5045337 in Patients With Solid Tumors (NCT01164033) | Hoffmann-La Roche | 2010-08-01 |
| Long-term Treatment for Cancer Patients With Deep Venous Thrombosis or Pulmonary Embolism (NCT01164046) | University Medical Center Groningen | 2010-08-01 |
| Clinical Study to Evaluate the Maximum Tolerated Dose of BAY1000394 Given in a 3 Days on / 4 Days Off Schedule in Subjects With Advanced Malignancies (NCT01188252) | Bayer | 2010-08-01 |
| A Study of RO5212054 (PLX3603) in Participants With BRAF V600-Mutated Advanced Solid Tumors (NCT01143753) | Hoffmann-La Roche | 2010-07-27 |
| BIBW 2992 (Afatinib) in Combination With Pemetrexed in Advanced Solid Tumours (NCT01169675) | Boehringer Ingelheim | 2010-07-01 |
| Phase I Study of BAY73-4506 in Chinese Patients With Advanced, Refractory Solid Tumors (NCT01096030) | Bayer | 2010-07-01 |
| Study of Anastrozole +/- AZD8931 in Postmenopausal Women With Endocrine Therapy Naive Breast Cancer (NCT01151215) | AstraZeneca | 2010-06-01 |
| First-in-human Study of AB0024 to Evaluate Safety and Tolerability in Adults With Advanced Solid Tumors (NCT01323933) | Gilead Sciences | 2010-06-01 |
| A Pilot Study of EZN-2968, an Antisense Oligonucleotide Inhibitor of HIF-1alpha, in Adults With Advanced Solid Tumors With Liver Metastases (NCT01120288) | National Cancer Institute (NCI) | 2010-04-29 |
| Clinical Study to Evaluate the Maximum Tolerated Dose of BAY79-4620 Given Every 2 Weeks to Patients With Advanced Solid Tumors (NCT01065623) | Bayer | 2010-04-01 |
| Radiation Dosimetry, Metabolism, Pharmacokinetics, Safety and Tolerability and PET Imaging With BAY94-9392 in Healthy Volunteers and Patients With Cancer or Inflammation (NCT01103310) | Lantheus Biosciences Ltd. | 2010-04-01 |
| Outlook: An Intervention to Improve Quality of Life in Serious Illness (NCT00939146) | Duke University | 2010-02-01 |
| Bioavailability and Food Effect Study of TKI258 (CSF Capsules vs. FMI Capsules)in Adult Patients With Advanced Solid Tumors (NCT01030055) | Novartis Pharmaceuticals | 2010-02-01 |
| A Phase I Study of Indenoisoquinolines LMP400 and LMP776 in Adults With Relapsed Solid Tumors and Lymphomas (NCT01051635) | National Cancer Institute (NCI) | 2010-01-25 |